MEDICENE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDICENE
Largest movements
- Receivables within one year -€24,619
no longer reported in 2025 (was €24,619)
of which Trade receivables: -€19,500
- Tangible fixed assets -€14,022
down €14,022 (-63.9%), from €21,943 to €7,921
- Cash +€10,711
up €10,711 (+7.6%), from €140,079 to €150,790
mainly Net result for the year (+€312,674) and Receivables within one year (+€24,619)
- Intangible fixed assets -€2,167
no longer reported in 2025 (was €2,167)
- Reserves +€68,851
up €68,851 (+242.8%), from €28,359 to €97,210
of which Distributable reserves: +€68,851
- Tax, wage and social debts -€62,244
down €62,244 (-58.3%), from €106,762 to €44,518
- Profit (loss) carried forward -€24,916
no longer reported in 2025 (was €24,916)
- Debts after one year -€11,437
no longer reported in 2025 (was €11,437)
- Gross operating margin -€160,528
down €160,528 (-27.0%), from €594,215 to €433,687
- Taxes -€38,723
down €38,723 (-27.6%), from €140,205 to €101,482
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €190,639 | €160,328 | -€30,311 | -15.9% |
| Fixed assets | 21/28 | €25,726 | €9,538 | -€16,189 | -62.9% |
| Intangible fixed assets | 21 | €2,167 | - | -€2,167 | |
| Tangible fixed assets | 22/27 | €21,943 | €7,921 | -€14,022 | -63.9% |
| Furniture and vehicles | 24 | €21,943 | €7,921 | -€14,022 | -63.9% |
| Financial fixed assets | 28 | €1,617 | €1,617 | = | 0.0% |
| Current assets | 29/58 | €164,912 | €150,790 | -€14,122 | -8.6% |
| Amounts receivable within one year | 40/41 | €24,619 | - | -€24,619 | |
| Trade receivables | 40 | €19,500 | - | -€19,500 | |
| Other amounts receivable | 41 | €5,119 | - | -€5,119 | |
| Cash at bank and in hand | 54/58 | €140,079 | €150,790 | +€10,711 | +7.6% |
| Deferred charges and accrued income | 490/1 | €214 | - | -€214 | |
| Total equity and liabilities | 10/49 | €190,639 | €160,328 | -€30,311 | -15.9% |
| Equity | 10/15 | €71,876 | €115,810 | +€43,935 | +61.1% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Contributions outside capital | 11 | €18,600 | €18,600 | = | 0.0% |
| Other | 1109/19 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €28,359 | €97,210 | +€68,851 | +242.8% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €26,499 | €95,350 | +€68,851 | +259.8% |
| Profit (loss) carried forward | 14 | €24,916 | - | -€24,916 | |
| Amounts payable | 17/49 | €118,763 | €44,518 | -€74,245 | -62.5% |
| Amounts payable after more than one year | 17 | €11,437 | - | -€11,437 | |
| Financial debts | 170/4 | €11,437 | - | -€11,437 | |
| Amounts payable within one year | 42/48 | €107,325 | €44,518 | -€62,808 | -58.5% |
| Trade debts | 44 | €564 | - | -€564 | |
| Suppliers | 440/4 | €564 | - | -€564 | |
| Taxes, remuneration and social security | 45 | €106,762 | €44,518 | -€62,244 | -58.3% |
| Taxes | 450/3 | €106,762 | €44,518 | -€62,244 | -58.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €21,709 | €17,822 | -€3,887 | -17.9% |
| Other operating charges | 640/8 | €908 | €937 | +€30 | +3.3% |
| Gross operating margin | 9900 | €594,215 | €433,687 | -€160,528 | -27.0% |
| Operating profit (loss) | 9901 | €571,598 | €414,928 | -€156,671 | -27.4% |
| Financial income | 75/76B | €17 | - | -€17 | |
| Recurring financial income | 75 | €17 | - | -€17 | |
| Financial charges | 65/66B | €197 | €772 | +€575 | +292.3% |
| Recurring financial charges | 65 | €197 | €772 | +€575 | +292.3% |
| Profit (loss) for the period before taxes | 9903 | €571,418 | €414,156 | -€157,262 | -27.5% |
| Income taxes | 67/77 | €140,205 | €101,482 | -€38,723 | -27.6% |
| Profit (loss) for the period | 9904 | €431,213 | €312,674 | -€118,539 | -27.5% |
| Profit (loss) for the period to be appropriated | 9905 | €431,213 | €312,674 | -€118,539 | -27.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.